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T cells have been demonstrated to modulate
ischemia–reperfusion injury (IRI) in kidney, lung, liver and
intestine. The underlying mechanisms for T-cell engagement
in IRI are unknown. We hypothesized that the T-cell receptor
(TCR) plays a role in renal IRI, and examined the effects of TCR
alpha/beta (ab) and gamma/delta (cd) deficiency on ischemic
acute renal failure (ARF). TCR-specific deficiency in specific
mice was confirmed by fluorescence-activated cell sorting
analysis using monoclonal antibodies (Abs). IRI was induced
by bilateral clamping of kidney pedicles for 30 min, followed
by reperfusion. Serum creatinine and kidney histopathology
were used to assess the severity of experimental ARF. TCR
ab-deficient mice were significantly protected from kidney
dysfunction compared to wild-type (WT) littermates after IRI
(Po0.05). Histologic analysis demonstrated a significant
reduction in renal tubular injury in both TCR ab- and
cd-deficient mice compared to WT mice postischemia. TCR
ab-deficient mice had reduced tumor necrosis factor-a and
interleukin-6 protein expression in kidney tissue compared to
WT mice at 24 h postischemia using a microbead-based
protein detection platform. Relative protection from kidney
IRI did not correlate with neutrophil and macrophage
infiltration of kidney tissue. Thus, the TCR plays a direct but
modest pathophysiological role in kidney IRI. These data
suggest that alloantigen-independent activation in IRI can
lead to engagement of antigen-specific molecules on T cells.
Furthermore, given that the TCR is already a target for
diagnostics and therapeutic strategies in immune diseases,
these approaches can now be harnessed for IRI.
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Ischemia–reperfusion injury (IRI) plays a major role in many
clinical conditions, including shock, stroke, myocardial
infarction, and solid organ transplantation. Kidney IRI is
the major cause of ischemic acute renal failure (ARF) in the
native and transplanted kidney. It is currently unclear why
allografts with significant IRI have a higher incidence of acute
rejection and poor long-term graft function.1–3 The patho-
genesis of kidney IRI is complex and only partially under-
stood. The role of inflammation in IRI has been increasingly
appreciated, with involvement of leukocytes, adhesion
molecules, chemokines, and cytokines. Recent studies from
a number of different laboratories have demonstrated that T
cells can directly mediate postischemic injury in the kidney4–7
as well as extra-renal organs such as liver, intestine, and
lung.8–10 CD4 T cells appear to be the major T cells involved
in IRI,5,11 and the Th1 phenotype is deleterious.12,13
Despite convincing data from different groups that T cells
participate in the pathogenesis of IRI, there is little
information on the underlying mechanisms. One important
question is whether the T-cell receptor (TCR) is involved in
IRI. Evidence for the participation of the TCR in IRI would
be important to direct future research into ‘classical’ path-
ways to study the T cell, as early T-cell engagement in IRI is
clearly a nonclassical concept. We hypothesized that the TCR
was directly involved in the pathogenesis of kidney IRI. We
evaluated the response to kidney IRI in mice deficient in TCR
ab or TCR gd T cells. We found that TCR ab-deficient mice
had a significant functional and structural protection from
kidney IRI, which in turn was associated with a decreased
level of tumor necrosis factor (TNF)-a and interleukin (IL)-6
proteins in postischemic kidney tissue compared with wild-
type (WT) mice, but not neutrophil and macrophage
infiltration. TCR gd-deficient mice had a structural protec-
tion from IRI, and had a slight but not statistically significant
functional protection as well. Thus, the TCR plays a direct
but moderate role in the full expression of postischemic
kidney damage.
RESULTS
Mice survival after IRI
WT mice had 33% mortality and TCR gd-deficient mice had
17% mortality. In contrast, all TCR ab-deficient and sham
mice survived 24 h after IRI and sham surgery, respectively
(n¼ 12/group) (Figure 1).
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Renal dysfunction after IRI
There were no statistically significant differences in the serum
creatinine (SCr) between groups before IRI or sham surgery.
At 24 h after IRI, TCR ab-deficient mice had significantly
lower SCr than WT mice (*Po0.05). TCR gd-deficient mice
showed a slight but not significant decrease in SCr compared
to WT mice (Figure 2).
TCR receptor expression
Flow cytometry was used to confirm the deficiency of TCR
ab or TCR gd among CD3-positive T cells (Figure 3). The
number of gated TCR ab- and gd-specific T cells in the
corresponding genetically modified mice were less than 1%.
Tubular injury scoring of TCR-deficient mice
SCr is a useful but imperfect marker of kidney function. It
does not gauge the effect of injury or an intervention on
different regions in the kidney, but total function. In order to
more carefully understand the effects of the TCR, we have
semiquantitatively dissected histologic responses to kidney
IRI in both WT and TCR knockout mice. Of importance is
that the scoring was performed in a blinded fashion by an
expert renal pathologist. Hematoxylin/eosin (H&E)-stained
postischemia kidney tissue was scored to determine the
severity of tubular injury. At 24 h after IRI, kidneys were
characterized by extensive damage with prominent tubular
necrosis and tubular dilation. There was vascular congestion
in peritubular capillaries of the outer medulla, as well as some
glomerular congestion. Renal injury was generalized rather
than patchy (Figure 4). TCR ab- and gd-deficient mice had
significantly decreased tubular injury, which was also found
when quantified by a blinded expert pathology reviewer
(Figure 5). However, vascular congestion was similar in the
different groups.
Leukocyte infiltration of kidney tissue after IRI
Leukocytes and other cells with phagocytic activity are
important mediators of inflammation and renal injury after
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Figure 1 | Survival of TCR-deficient mice and WT mice at 24 h
after IRI (n¼ 12 in each group).
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Figure 2 | Renal function 24 h after IRI in TCR ab-, cd-deficient,
and WT mice (n¼ 12 in each group). *Significant difference
between WT and TCR ab-deficient mice; Po0.05.
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Figure 3 | Flow cytometry analysis confirms the deficiency of TCR
ab and cd CD3þ cells in TCR ab- and cd-deficient mice,
respectively.
a b
c d
Figure 4 | Histopathology of postischemic kidney tissue by H&E,
original magnification  64 in (a) sham, (b) WT, (c) TCR ab-, and
(d) cd-deficient mice at 24 h postischemia.
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ischemia/reperfusion. It was shown that the myeloperoxidase
(MPO) assay measures neutrophil infiltration and also
detects macrophages.7 We used the MPO assay in this study
as a measure of both neutrophil and macrophage infiltration.
MPO analysis of kidney homogenates revealed no differences
in neutrophil and macrophage infiltration (P40.05) at
24 h after experimental IRI (Figure 6) between WT, TCR
ab-, and gd-deficient mice (0.03970.004, 0.04770.002, and
0.03970.002 absorbance (abs)/min/mg, respectively).
Kidney cytokine profile
Cytokines are potential effector molecules that modulate and
regulate immune responses. There was a large increase in
TNF-a in kidney tissue after IRI in all groups, but not in the
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Figure 5 | Tubular injury scoring of kidney at 24 h postischemia in
WT, TCR ab-, and cd-deficient mice. CT: convoluted tubule,
SS: straight segment, OS: outer stripe, IS: inner stripe.
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Figure 6 | Neutrophil and macrophage infiltration into the post
ischemic kidney using the MPO assay. No significant difference
between WT, TCR ab, and gd deficient mice at 24 h post ischemia.
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Figure 7 | Proinflammatory cytokine and chemokine levels (pg/ml) at 24 h after IRI in kidney tissue homogenate. (a) TNF-a, (b) IL-6,
(c) IL-1b, (d) IL-2, (e) IFN-g, and (f) RANTES. *Significant difference between WT and TCR ab-deficient mice; Po0.05.
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sham-operated animals (Figure 7a). TNF-a concentration in
WT animals was almost 6.5 times higher compared to normal
levels, and four times higher than after sham surgery. In
TCR-deficient mice, IRI also led to an elevation of TNF-a in
kidney tissue, but this was blunted. Significant differences
between TNF-a in WT and TCR ab-deficient mice were also
observed (Po0.05). Statistically significant changes in IL-6
concentration after IRI between groups were also found
between WT and TCR ab-deficient mice (Figure 7b). We did
not find any statistically significant differences among any
groups in IL-1b concentration after IRI or sham surgery
(Figure 7c). Concentration of IL-2 decreased in WT and both
types of TCR-deficient mice, but not after sham surgery
(Figure 7d), which was unexpected. RANTES was elevated in
all operated animals without differences between them, and
probably responded to anesthesia and surgical induced stress
rather than kidney IRI (Figure 7f). The same pattern was
noted in interferon (IFN) g concentration (Figure 7e).
DISCUSSION
In the last few decades, there have been significant data
demonstrating the participation of T cells in classically
‘nonimmune’ responses such as IRI, burns, trauma, and
sepsis.14 An important current area of investigation is the
mechanisms by which T cells mediate IRI. It is unknown if
T-cell engagement in IRI involves the more ‘classic’ signal 1
pathways mediated through the TCR. The present data
demonstrate that TCR ab-deficient mice have improved
survival, decreased renal dysfunction, and tubular injury after
IRI compared to WT littermate strain- and sex-matched
mice. TCR gd-deficient mice also have a slightly reduced
mortality, renal dysfunction, and structural injury compared
to WT, but not as marked as TCR ab-deficient mice. The
acute tubular necrosis (ATN) regional scoring demonstrates
reduced tubular injury in convoluted tubules, the straight
segment of the cortex, and inner stripe of medulla in TCR
ab- and gd-deficient mice compared to WT. This is consistent
with the decrease in mortality and relative decrease in
rise in SCr. The more marked protection in the inner stripe
of the TCR ab-deficient mice could be important in
explaining why this strain was more protected than the
TCR gd-deficient strain. The apparent dissociation in
histology and function is likely indicating that changes in
SCr do not precisely reflect changes in kidney structure. After
severe warm I/R renal injury, a pronounced acute tubular
injury occurs during the first 12–24 h with an increase in renal
MPO activity, reflecting the infiltration of activation of
polymorphonuclear cells and macrophages.7 We did not
observe a difference in MPO level between groups to
potentially invoke phagocyte trafficking changes as the
potential mechanism underlying the TCR effect. However,
we cannot exclude that more in-depth studies of MPO levels
at different time points postischemia would have revealed a
more subtle change in the kinetics of the MPO increase.
Postischemic proinflammatory cytokine expression revealed
an attenuated rise in TNF-a and IL-6 in TCR-deficient mice,
which suggests that these cytokines are potential mediators of
the TCR-mediated IRI.
ab T cells are subdivided into two distinct nonoverlapping
populations, one that expresses CD4 and the other CD8.
Thus, TCR ab-deficient mice are also CD4/CD8 deficient.
The current data are consistent with previously published
data on CD4/CD8 deficiency, conferring functional, and
structural protection from renal IRI.4 Furthermore, in vivo
depletion of T cells in WT mice was protective in IRI of the
kidney.15 Reconstitution of T-cell-deficient athymic nu/nu
mice with WT T cells restored postischemic injury.5 gd T cells
are frequently found in mucosal epithelium, but form only a
minor population of circulating T-cell subsets. These cells do
not express CD4 or CD8. We found that deficiency of gd T
cells conferred a structural protection from renal IRI similar
to ab deficiency; however, there was less protection in terms
of functional changes, attenuation of TNF-a and IL-6
increase, and mortality.
Few T cells infiltrate into mouse kidney at 24 h after IRI;
thus, T cells are likely orchestrating their effect through other
pathways rather than being the final mediators of kidney
dysfunction and tubular necrosis.5 It was shown that
blocking the costimulatory pathway by CTLA-4 immuno-
globulin, reactive with both B7-1 and B7-2 costimulatory
molecules, protects the kidney during acute ischemia/
reperfusion injury. As soon as 2 h after reperfusion, B7-1
was expressed along the endothelial cells of the ascending
vasa recta and expression of B7-1 increased over time during
the first 24 h and adherence/accumulation of T cells and
monocytes/macrophages was found in the vasa recta of the
ischemic kidney.16 Thus, IRI involves early T-cell congestion
of the capillaries, which could then facilitate congestion by
other inflammatory cells.16 We did not observe a difference in
vascular congestion between our experimental groups using
detailed light microscopy analysis, but more in-depth studies
using special techniques in the future could reveal key
differences. We found that TNF-a protein levels increased
after IRI in WT mice, and this increase was blunted in TCR-
deficient mice. TNF-a has been found to be upregulated after
IRI17–19 and TNF-a neutralization also inhibits ischemia-
induced renal tubular cell apoptosis.20,21 Thus, our current
data in the context of that of other groups suggest that TNF-a
production could be a downstream effector of the TCR’s role
in IRI. IL-6 has also been invoked in kidney IRI injury,22 is
likely important, but not studied in depth so far. The
attenuated IL-6 increase in the TCR ab knockouts compared
to WT mice postischemia could also have played a relative
protection seen in the TCR-deficient mice. Levels of IL-1
protein in kidney tended to decrease uniformly after ischemia
in WT mice as well as in the TCR-deficient mice. Contrary to
our expectations, IL-2 and IFN g protein levels decreased in
postischemic kidney in all groups compared to normal or
sham-operated mice. Studies investigating postischemic IL-2
levels have been controversial, with varying levels of IL-2
measured. Some studies have found a high expression23
compared to studies showing minimally increased or even
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undetectable levels postischemia.17 This may reflect differ-
ences in the model or detection techniques used. The drop in
IL-2 levels in the kidney tissue in both TCR-deficient mice
and in WT was studied with an ‘n’ of 6 per group and then
was confirmed with an ‘n’ of 10 per group, but did not reach
statistical significance. Thus, we are confident of these data.
The mechanisms of the trend for a decrease in IL-2 proteins
in both WT and TCR-deficient mice kidneys remain unclear
and are beyond the scope and goals of the current study.
RANTES levels also decreased, in contrast to a greater than
10-fold increase at 6 weeks postischemia.24
We note that the effects of the TCR deficiency are not as
profound as total T-cell absence, as published previously.5
Ischemic ARF involves alterations in renal perfusion,
continued hypoxia and inflammatory processes, all of which
contribute to continued tubular cell injury.25 However, we
did find a protection in mortality, renal function, histology,
and generation in TNF and IL-6 in TCR-deficient mice,
particularly TCR ab-deficient mice. Clinically, even a modest
(e.g. 10% protection) kidney function is sufficient to
maintain survival off dialysis. Thus, even the mechanisms
and therapies for modest changes are important.
In a number of published studies from our group,5 T-cell
reconstitution leads to enhanced tissue injury in ARF. A recently
published paper26 demonstrates similar effects on murine ARF
if T-cell costimulation is blocked in a sepsis model of ARF, and
T-cell repletion increases the injury responses.
The current data identify TCR as one of the patho-
physiological mediators of kidney IRI. This implicates the early
engagement of signal 1 (TCR-HLA) in kidney IRI, despite IRI
being a classically ‘nonimmune’ disease lacking alloantigen.
Further dissection of signal 1 pathways in IRI will assist in
elucidating the mechanisms by which T cells modulate IRI
in kidney and other organs. Identification of a role for TCR
in kidney IRI could also lead to new therapies for this
common and lethal disease.
MATERIALS AND METHODS
Mice
TCR ab- (B6.129P2-Tcrbtm1Mom), TCR gd-deficient mice
(B6.129P2-Tcrdtm1Mom), and background-strain matched WT
littermates were purchased from The Jackson Laboratory (Bar
Harbor, ME, USA). Mice deficient in TCR ab have normal
differentiation of gd thymocytes.27 TCR gd-deficient mice have
normal development of the ab T-cell lineage. Patterns of
CD4þCD8 and CD4CD8þ ab T cells are apparently normal
in the TCR gd-deficient mice.28 Mice were housed under pathogen-
free conditions, according to NIH guidelines. All studies conducted
have been reviewed and approved by the John Hopkins animal care
and use committee. To confirm TCR deficiency status, spleens, and
lymph nodes from each group of mice were collected upon killing
and analyzed using flow-cytometric analysis.
Renal ischemia–reperfusion model
An established model of renal IRI was used.29Animals were
anesthetized with 75 mg/kg intraperitoneal sodium pentobarbital.
Under aseptic conditions, abdominal incisions were made, and the
renal pedicles were bluntly dissected. A microvascular clamp was
placed on both renal pedicles for 30 min, a well-characterized
ischemia time. During surgery, animals were well hydrated with
saline and kept at a constant temperature (B371C). After the
clamps were removed, the wounds were sutured and the animals
were allowed to recover.
Assessment of postischemic renal function
Blood samples were obtained from the tail vein at 0 and 24 h after
ischemia. SCr (mg/dl) was measured on a Roche Cobas Fara
automated system (Roche, Nutley, NJ, USA) using a Creatinine 557
kit (Sigma Diagnostics, St Louis, MO, USA).
Tissue histological examination
At 24 h after ischemia, kidneys were dissected from mice, and
coronal tissue slices were fixed in 10% formalin and processed for
histological examination using standard techniques. Formalin-fixed
tissue was embedded in paraffin and 4-mm sections were cut. H&E-
stained sections were examined in a blinded fashion by a pathologist
to evaluate the degree of tubular necrosis. The magnitude of cell loss
and necrosis was scored based on five levels. Scores ranged from 0 to
4 based on the percentage of tubules affected (0: o10%; 1: 10–25%;
2: 25–50%; 3: 50–75%; 4: 475%).
Flow-cytometric analysis
Postischemic spleens were crushed in 5 ml of Hank’s balanced salt
solution (HBSS)-2 using five strokes in a glass homogenizer. Cells
were collected by centrifugation at 250 g for 10 min. They were then
resuspended in ammonium chloride/potassium buffer for 5 min to
remove red blood cells. Cells were washed three times with ice-cold
HBSS-2 and filtered through a 70-mm nylon screen to remove
debris. For each analysis, 106 cells were treated with an Fc block for
5 min, and then stained with 0.5 mg R-PE rat anti-mouse CD3e
antibody (Ab) and fluorescein isothiocyanate (FITC)-conjugated
anti-mouse TCR b and g Abs or isotype controls (PharMingen, San
Diego, CA, USA) for 1 h on ice. Cells were then washed twice, fixed
in 1% formalin, and analyzed on an Epics XL flow cytometer using
System II software (Beckman Coulter, Fullerton, CA, USA).
Leukocyte detection using MPO assay
Leukocyte (phagocyte) infiltration was measured in mouse kidney
tissue 24 h after IRI.
Kidney samples were homogenized (1:20 wt/vol) in ice-cold
KPO4 buffer. Homogenate samples were spun at 17 000 g for 30 min
at 41C, and pellets were washed and spun an additional two times.
Then, 0.5% hexadecyltrimethylammonium bromide-10 mM EDTA
was added to the remaining pellet (6:1). Suspensions were sonicated
and freeze–thawed three times and then incubated at 41C for 20 min.
After final centrifugation at 17 000 g at 41C for 15 min and addition
of assay buffer (4:1), supernatants were measured for MPO. Change
in absorbance over 3.5 min was recorded at 460 nm. One unit of
MPO was defined as a change of absorbance of 1/min. Results were
expressed as abs/min/100 mg of wet tissue that was detected using a
bicinchoninic assay (Pierce Chemical, Rockport, IL, USA).
Measurement of cytokines level in kidney tissue
Weighed kidney samples containing 500mg/ml of protein per sample
(measured by bicinchoninic acid (BCA) (Pierce Chemical Co,
Rockford, IL, USA) as per the manufacturer’s instructions) were
homogenized with cell lysis buffer (Cell Lysis Kit, Bio-Rad
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Laboratories Inc., Hercules, CA, USA). Tissue homogenates were
centrifuged at 12 000 r.p.m. for 15 min at 41C and supernatants
collected and used for the cytokine multiplex (IL-1b, IL-2, IL-6,
IFN-g, TNF-a, and RANTES) bead-based immunoassay kit (Bio-
Rad Laboratories Inc., Hercules, CA, USA). Cytokine assay plate
layout consisted of eight standards in duplicate (32 000–1.95 pg/ml),
two blank wells (for background fluorescence subtraction), and each
sample in duplicate wells. The cytokine multiplex assay uses a
microbead and flow-based protein detection system (Bio-Plex
Suspension Array System, Bio-Rad Laboratories Inc., Hercules,
CA, USA) based on the Luminex xMAP technology. In this
quantitative assay, surfaces of fluorescence-coded microbeads are
conjugated to specific Abs directed against each cytokine or
chemokine. Each fluorescence-coded microbead type is conjugated
to one specific capture Ab, and consequently one specific target
analyte. Each supernatant sample was first incubated with a mixture
of all microbead types for 90 min at room temperature. Samples
were then washed, incubated with a mixture of secondary
biotinylated detection Abs also directed against each target for
30 min at room temperature, washed again, and incubated with a
streptavidin-coupled phycoerythrin reporter system for 10 min at
room temperature. After a final wash, the samples were resuspended
in buffer and subjected to flow-cytometric analysis. The Bio-Plex
system instrument uses fluidics, laser excitation, fluorescence
detection, and digital signal processing for individual scanning
and microbead identification. Each bead taken from the sample was
identified based on its internal fluorescence signature, and the
phycoerythrin reporter signal associated with that bead was
quantified. The data were analyzed using Bio-Plex ManagerTM 3.0
software (Bio-Rad Laboratories Inc., Hercules, CA, USA).
Statistical analysis
The experimental data were expressed as mean value7s.e.
Differences between the groups were tested by unpaired Student’s
t-test and Po0.05 was considered to be statistically significant.
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